Skip to main content
. 2021 Aug 27;60:70–77. doi: 10.1016/j.breast.2021.08.014

Fig. 3.

Fig. 3

Patient-reported global health status/quality of life (GHS/QoL) over time: (A) By chemotherapy partner and (B) By age. BEV–CAP, bevacizumab plus capecitabine; BEV–PAC, bevacizumab plus paclitaxel.